International Experts Unite at Cellex Symposium 2025 to Explore Innovations in Cell and Gene Therapy

Cellex Symposium 2025: A Cutting-Edge Forum for Cell and Gene Therapy Enthusiasts

On November 6, 2025, the landscape of cell and gene therapy experienced a significant event as Cellex Cell Professionals GmbH convened an international symposium in Frankfurt/Main, Germany. This pivotal meeting brought together over 100 professionals from distinctive regions including Europe, Asia, and North America. It was a gathering of minds encompassing scientists, clinicians, investors, regulatory authorities, and industry leaders to deliberate on the rapidly changing environment of Cell and Gene Therapy (CGT).

Dr. Armin Ehninger, the Chief Scientific and Strategic Officer of Cellex, opened the symposium with profound insights. He emphasized the company’s commitment to facilitating advancement in CGT through scientific excellence, collaboration, reliable manufacturing processes, and adherence to stringent quality standards. According to Dr. Ehninger, these factors are crucial to fostering innovation and establishing robust networks that can bring about meaningful advancements in therapies.

A Focus on Innovation in Immune Cell Therapies

The symposium kick-started with an engaging session centered on driving innovation and investment in next-gen immune cell therapies. Dr. Karl Nägler from Sofinnova Partners presented a compelling overview that highlighted the current venture capital landscape, elucidating both opportunities and barriers in CGT investments. Meanwhile, Kenneth Locke shared insights on innovative approaches using cell-derived nanoparticles to address critical challenges in T cell activation and proliferation.

Furthermore, Dr. Jiri Eitler from the Dresden University of Technology introduced novel accessibility strategies regarding CAR-NK therapies, expanding their applications beyond traditional oncology. Contributing to this insightful dialogue, Dr. Jessica Hartmann, from the Paul-Ehrlich-Institute, stressed that sustained innovation hinges upon establishing frameworks capable of translating pioneering scientific developments into scalable, high-quality manufacturing processes – an area in which Cellex is already setting remarkable standards.